LCN2 and cancer: The data demonstrated that concordance of NGAL at both mRNA and protein levels was obtained for the following cancer types: bladder, colorectal, liver, lung, ovarian, and pancreatic (Table 1 and Figure 4, Panels: A, E, I, J, H and L).